Versant Venture Management as of March 31, 2024
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Stock (CRSP) | 32.9 | $34M | 499k | 68.16 | |
| Skye Bioscience Common Stock | 30.4 | $31M | 2.0M | 15.64 | |
| Repare Therapeutics Common Stock (RPTX) | 12.1 | $13M | 2.6M | 4.71 | |
| Gritstone Oncology Common Stock (GRTS) | 8.9 | $9.2M | 3.6M | 2.57 | |
| Adverum Biotechnologies Common Stock | 6.9 | $7.2M | 507k | 14.14 | |
| Passage Bio Common Stock (PASG) | 6.5 | $6.7M | 5.0M | 1.35 | |
| Aligos Therapeutics Common Stock (ALGS) | 2.2 | $2.3M | 2.3M | 0.98 |
